Jefferies Financial Group
RARE icon

Jefferies Financial Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Jefferies Financial Group’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.1M Buy
1,339,814
+410,188
+44% +$9.8M 0.15% 123
2026
Q2 		$31M Buy
929,626
+914,138
+5,902% +$22.7M 0.2% 97
2026
Q1 		$324K Sell
15,488
-461,604
-97% -$10.4M ﹤0.01% 1355
2025
Q4 		$11M Buy
+477,092
New +$15.7M 0.06% 300
2024
Q3 		– Sell
-10,250
Closed -$421K – 1710
2024
Q2 		$421K Buy
+10,250
New +$438K ﹤0.01% 1016

Other funds holding RARE

GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Jefferies Financial Group's RARE Position: Q3 2026 in Review

Jefferies Financial Group increased its Ultragenyx Pharmaceutical (RARE) stake by 44% in Q3 2026, buying an estimated $9.8M and bringing the position to 1,339,814 shares worth $20.1M. The position accounts for 0.15% of the portfolio, ranked #123.

Jefferies Financial Group first reported a position in RARE in Q2 2024 and has held it in 5 quarters since. The position peaked at $31M in Q2 2026. 113 funds tracked by Wall St. Rank hold RARE as of Q3 2026.

  • Jefferies Financial Group held 1,339,814 shares of Ultragenyx Pharmaceutical worth $20.1M as of Q3 2026.
  • Jefferies Financial Group bought 410,188 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $9.8M.
  • Ultragenyx Pharmaceutical made up 0.15% of Jefferies Financial Group's portfolio in Q3 2026, its #123 holding.
  • Jefferies Financial Group first reported a position in Ultragenyx Pharmaceutical in Q2 2024 and has held it in 5 quarters since.
  • Jefferies Financial Group's Ultragenyx Pharmaceutical position peaked at $31M in Q2 2026.
  • 113 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.